BioWa(日本)

BioWa

日本BioWawww.biowa.com www.kyowa-kirin.co.jpBioWa是日本制藥公司和的生物科技公司協(xié)和發(fā)酵工業(yè)株式會(huì)社(KyowaHakkoKogyoCo.,Ltd.)旗下全資子公司，也是AccretaMab(R)平臺(tái)的全球授權(quán)商。AccretaMab(R)平臺(tái)由POTELLIGENT(R)技術(shù)和COMPLEGENT(R)技術(shù)組成，創(chuàng)造了一個(gè)擁有更強(qiáng)ADCC和CDC活性的 優(yōu)質(zhì)抗體分子。BioWa目前正根據(jù)授權(quán)向合作伙伴提供POTELLIGENT(R)和COMPLEGENT(R)技術(shù)，以限度提升這些技術(shù)的價(jià)值。BioWa還與協(xié)和發(fā)酵工業(yè)株式會(huì)社共同專注于ADCC/CDC增強(qiáng)型單克隆抗體療法的開發(fā)，以抗擊癌癥和其它危及生命并使人體衰弱的疾病。BioWaiscommittedtoimprovinghealththroughadvancementsinlifescienceandtechnology.Thisdedicationtohumanhealthhasgivenimpetustothediscoveryanddevelopmentofatechnologythathasthepotentialtoimprovetheeffectivenessofantibody-basedtreatmentsacrossmanytherapeuticcategories.BioWa,Inc.,aNewJersey-basedbiotechcompany,wasincorporatedinDelawarein2003.BioWaiscommittedtoimprovinghealththroughadvancementsinlifescienceandtechnology.Thisdedicationtohumanhealthhasgivenimpetustothediscoveryanddevelopmentofatechnologytha